Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Biochimica Et Biophysica Acta|June 1, 2000
Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residuesY Mizutani, K Tamiya-Koizumi, F Irie, et al.
Molecular Immunology|June 1, 1995
Cytotoxic T cell recognition of a human melanoma derived peptide with a carboxyl-terminal alanine-proline sequenceN Morioka, Y Kikumoto, D S Hoon, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1982
Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2L D Cahan, R F Irie, R Singh, et al.
Cancer Research|April 15, 1991
Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factorD S Hoon, M Banez, E Okun, et al.
International Archives of Allergy and Applied Immunology|January 1, 1990
Hanganutziu-Deicher antigen as a possible target for immunotherapy of melanomaH Nakarai, P J Chandler, K Kano, et al.
Clinical and Experimental Immunology|January 1, 1980
A serologic study of cultured breast cancer cell lines: lack of antibody response to tumour specific membrane antigens in patientsM Higuchi, D S Robinson, R Cailleau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1994
A decapeptide (Gln-Asp-Leu-Thr-Met-Lys-Tyr-Gln-Ile-Phe) from human melanoma is recognized by CTL in melanoma patientsN Morioka, Y Kikumoto, D S Hoon, et al.
Cancer Research|October 15, 1991
Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomasD S Hoon, E Okun, M Banez, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1986
Radioimmunodetection of human melanoma tumor xenografts with human monoclonal antibodiesM Gomibuchi, R E Saxton, R R Lake, et al.
The Journal of Investigative Dermatology|February 16, 1999
IgM anti-ganglioside antibodies induced by melanoma cell vaccine correlate with survival of melanoma patientsT Takahashi, T D Johnson, Y Nishinaka, et al.
Pageof 12